Tag:
Favrille
Latest Headlines
Latest Headlines
Following trial failure, Favrille cuts staff
San Diego's Favrille is making massive cuts following the trial failure of Specifid announced earlier this week. The company is axing 132 of its 144 employees, including six of its eight executive
Favrille dumps Specifid after trial failure
San Diego-based Favrille has halted development of Specifid, a treatment for follicular B-cell non-Hodgkin's lymphoma. In a Phase III trial the drug failed to show a statistically significant
